VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK 6802892

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2019-05-28 for VITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK 6802892 manufactured by Ortho-clinical Diagnostics.

Event Text Entries

[146637211] The investigation determined that higher than expected vitros ipth results were obtained from two different samples collected from the same patient, tested on a vitros 5600 integrated system, when compared to results obtained from a non-vitros (roche) system. The investigation determined the assignable cause of the event was the presence of heterophilic antibodies in the patient? S sample that are interfering with the vitros ipth assay. The? Other limitations? Section of the vitros ipth ifu, contains the following statement:? Heterophilic antibodies in serum or plasma samples may cause interference in immunoassays. These antibodies may be present in blood samples from individuals regularly exposed to animals or who have been treated with animal serum products. Results which are inconsistent with clinical observations indicate the need for additional testing?. Based on the historical ipth quality control performance, a vitros ipth reagent issue is not a likely contributing factor to this event. Ongoing tracking and trending of complaint data has not identified any signals to suggest there is a systemic quality issue with vitros ipth reagent lot 0930 or vitros ipth reagent lot 1010. In addition, there was no indication of a vitros 5600 system issue and an instrument malfunction is not a likely contributor to the event.
Patient Sequence No: 1, Text Type: N, H10


[146637212] A customer obtained higher than expected vitros ipth results from two different samples collected from the same patient, tested on a vitros 5600 integrated system, when compared to results obtained from a non-vitros (roche) system. 2018 patient sample vitros ipth result of 160. 5 pg/ml versus the expected roche result of 61 pg/ml. 2019 patient sample vitros ipth result of 126. 1 pg/ml versus the expected roche result of 57 pg/ml. Biased results of the direction and magnitude observed may lead to inappropriate physician action if undetected. The higher than expected vitros ipth results were reported outside the laboratory. However, the results were questioned by a clinician. There was no allegation of actual patient harm as a result of this event. This report is number two of two mdr? S for this event. Two 3500a forms are being submitted for this event as two devices were involved. This report corresponds to ortho clinical diagnostics inc (ortho). Complaint numbers (b)(4).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number3007111389-2019-00092
MDR Report Key8645359
Date Received2019-05-28
Date of Report2019-05-28
Date of Event2018-09-20
Date Mfgr Received2019-05-02
Device Manufacturer Date2018-03-15
Date Added to Maude2019-05-28
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. JAMES A STEVENS
Manufacturer Street100 INDIGO CREEK DRIVE
Manufacturer CityROCHESTER NY 14626
Manufacturer CountryUS
Manufacturer Postal14626
Manufacturer Phone5854533000
Manufacturer G1ORTHO CLINICAL DIAGNOSTICS
Manufacturer StreetFELINDRE MEADOWS PENCOED
Manufacturer CityBRIDGEND, WALES CF355PZ
Manufacturer CountryUK
Manufacturer Postal CodeCF35 5PZ
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameVITROS IMMUNODIAGNOSTIC PRODUCTS INTACT PTH REAGENT PACK
Generic NameIN-VITRO DIAGNOSTIC
Product CodeCEW
Date Received2019-05-28
Catalog Number6802892
Lot Number0930
Device Expiration Date2018-11-26
OperatorHEALTH PROFESSIONAL
Device AvailabilityY
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerORTHO-CLINICAL DIAGNOSTICS
Manufacturer Address100 INDIGO CREEK DRIVE ROCHESTER NY 14626 US 14626


Patients

Patient NumberTreatmentOutcomeDate
10 2019-05-28

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.